Scientific paper
Perioperative immunomodulation in cancer surgery

https://doi.org/10.1016/0002-9610(94)90070-1Get rights and content

Abstract

Despite undergoing a curative resection, many patients with colorectal cancer will develop and die of metastatic disease. It has been shown clinically and experimentally that surgery causes a transient period of immunosuppression, and it is postulated that this may encourage both the implantation of surgically disseminated tumor cells and the growth of existing micrometastases. The present study used natural killer cell cytotoxicity (NKCC) and tumor burden to evaluate perioperative modulation of immunocompetence in a murine model. We measured NKCC and tumor burden responses to a standardized surgical stress (SSS) alone, and to either morphine sulfate (MS) (15 mg/kg subcutaneously × 4 doses), ketorolac (a prostaglandin synthetase—prostaglandin E2—inhibitor) (2.5 mg/kg subcutaneously X 4 doses), or interleukin 2 (2,000 units intraperitoneally × 3 doses) administration with the SSS.

In this model, we found that both low-dose interleukin-2 (IL-2) and ketorolac reversed the NKCC suppression associated with surgery, whereas morphine resulted in further depression of NKCC. In addition, IL-2 significantly decreased tumor incidence, whereas continuous MS exposure markedly increased tumor burden after surgery. These data suggest that IL-2 and ketorolac may be effective agents for the restoration of perioperative immune competence, whereas the use of continuous morphine might have significant deleterious effects.

References (40)

  • T Wiggers et al.

    No-touch isolation technique in colon cancer: a controlled prospective trial

    Br J Surg

    (1988)
  • LP Fielding et al.

    Survival after primary and after staged resection for large bowel obstruction caused by cancer

    Br J Surg

    (1974)
  • JL Weese et al.

    Reduced incidence of hepatic metastases by perioperative treatment with recombinant human interleukin-2

    Dis Colon Rectum

    (1987)
  • SA Rosenberg et al.

    Experience with the use of high dose IL-2 in the treatment of 652 cancer patients

    Ann Surg

    (1989)
  • PG Horgan et al.

    Effect of low dose recombinant interleukin 2 plus indomethacin on mortality after sepsis i a murine burn model

    Br J Surg

    (1990)
  • J Lundy et al.

    Halothane, surgery, immunosuppression and artificial pulmonary metastases

    Cancer

    (1978)
  • J Neter et al.

    Applied linear statistical models

    (1985)
  • H Wexler

    Accurate identification of experimental pulmonary metastases

    J Natl Cancer Inst

    (1966)
  • R Lafreniere et al.

    A novel approach to the identification of experimental hepatic metastases in a murine model

    J Natl Cancer Inst

    (1986)
  • MP Yeager et al.

    Effect of morphine on growth of metastatic colon cancer in vivo

    Arch Surg

    (1991)
  • Cited by (0)

    Presented at the 34th Annual Meeting of The Society for Surgery of the Alimentary Tract, Boston, Massachusetts, May 17–19, 1993.

    View full text